Advertisement Supported by Users of New Weight Loss Drug Had Lower Blood Pressure in Study The patients used tirzepatide, sold as Mounjaro or Zepbound, but researchers could not distinguish the effect of the drug from the effects of weight loss
[DOI] [PubMed] [Google Scholar] 88.Barbosa-Yanez R.L., Markova M., Dambeck U., Honsek C., Machann J., Schuler R., Kabisch S., Pfeiffer A.F.H
Strictly adhering to the prescribed titration schedule is criticalpatients should not increase doses more rapidly than recommended, even if tolerating the current dose well, as this increases the risk of prolonged side effects
Managing blood sugar peaks and improving fullness cues reduces overeating and stabilizes energy levels throughout the day